Notice of Correction to RFA-HL-26-014 NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
National Institutes of Health
Type
Research/project funding
Posted on:
Notice NOT-HL-25-006 from the NIH Guide for Grants and Contracts